Riskpilot← Back to searchSign inGet full accessFANA APOTEK AS
ASActiveOrg 999539858Østre Nesttunvegen 4, 5221 NesttunRetail sale of pharmaceutical products · NACE 4773Est. 201316 employees
Revenue 2025
NOK 0
EBITDA margin
—
+83% vs 2024
Equity ratio
-39573.2%
Financial strength
Net profit 2025
NOK -19K
+83% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -19K | +83% |
| Net profit | NOK -19K | +83% |
| Total assets | NOK 7K | -98% |
| Equity | NOK -2,9M | -1% |
| Employees | 16 | — |
Legal name
FANA APOTEK AS
Org number
999539858
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
16. januar 2013
Share capital
NOK 1 000 000
Employees
16 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eierskap og drift av apotek, handel med apotekvarer og relaterte produkter, aktuelle konsulent og rådgivningstjenester.
Address
Østre Nesttunvegen 4, 5221 Nesttun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 14 757 | 14 139 | 4 695 | 0 | 0 |
| Staff expenses | −2 969 | −3 150 | −1 316 | 5 | −0 |
| EBITDA | −454 | −862 | −839 | −111 | −19 |
| Depreciation & amort. | −133 | −117 | −0 | −0 | −0 |
| EBIT | −588 | −980 | −839 | −111 | −19 |
| Net financials | 1 | 1 | 1 | 1 | 0 |
| Profit before tax | −587 | −979 | −838 | −110 | −19 |
| Tax | −175 | −0 | −0 | −0 | −0 |
| Net profit | −412 | −979 | −838 | −110 | −19 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 328 | 2 723 | 519 | 375 | 7 |
| Equity | −1 473 | −2 452 | −2 801 | −2 911 | −2 930 |
| Long-term debt | 2 304 | 2 059 | 3 394 | 3 285 | 0 |
| Short-term debt | 3 497 | 3 116 | −74 | 1 | 2 |
| Total debt | 5 801 | 5 175 | 3 320 | 3 287 | 2 937 |
EBITDA margin
-1872700.0%
This company
15.8%
Market median
-11852632% vs market
20212025
Equity ratio
-39573.2%
This company
38.2%
Market median
-103695% vs market
20212025
Return on equity
-1858600.0%
This company
18.4%
Market median
-10101187% vs market
20212025
Net profit margin
-1858600.0%
This company
8.1%
Market median
-22945779% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mckesson Norway Holding As
FANA APOTEK AS Board members of FANA APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Erik Helgemo | Deputy Member | 0 companies |
| Håvard Røkke | Chairman | 0 companies |